GT Biopharma Inc (GTBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GTBP | EDSA | VRAX | ||
| Company | GT Biopharma Inc | Edesa Biotech Inc | Virax Biolabs Group Limited | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 3.01 | 2.08 | 1.96 | ||
| High | 3.15 | 2.21 | 2.10 | ||
| Low | 2.82 | 2.08 | 1.91 | ||
| Last | 3.06 | 2.17 | 2.01 | ||
| Change | +0.05 | +0.06 | +0.07 | ||
| % Change | +1.66% | +2.84% | +3.61% | ||
| Volume | 12,000 | 4,400 | 204,100 | ||
| 20-Day Average Volume | 21,770 | 49,565 | 272,300 | ||
| Previous Close | 3.01 | 2.11 | 1.94 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 3.09 | 2.59 | 2.03 | ||
| 20-Day Raw Stochastic | 42.67% | 7.26% | 33.78% | ||
| 20-Day Relative Strength | 56.09% | 27.56% | 48.93% | ||
| Weighted Alpha | -56.51 | -51.41 | -83.62 | ||
| Today's Opinion | 8% Buy | 100% Sell | 16% Buy | ||
| Previous Opinion | 8% Buy | 100% Sell | 16% Buy | ||
| Last Month's Opinion | 8% Sell | 100% Sell | 56% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +4.79% since 11/15/24 | +3.33% since 11/15/24 | +12.29% since 11/15/24 | ||
| Low | 2.73 on 11/18/24 | 2.05 on 11/21/24 | 1.76 on 11/18/24 | ||
| High | 3.20 on 11/20/24 | 2.32 on 11/19/24 | 2.10 on 11/22/24 | ||
| 1-Month | |||||
| %Chg | +20.47% since 10/22/24 | -42.29% since 10/22/24 | +19.64% since 10/22/24 | ||
| Low | 2.54 on 10/23/24 | 2.05 on 11/21/24 | 1.76 on 11/18/24 | ||
| High | 3.55 on 10/24/24 | 3.93 on 10/24/24 | 3.62 on 10/23/24 | ||
| 3-Month | |||||
| %Chg | +41.67% since 08/22/24 | -51.24% since 08/22/24 | -61.20% since 08/22/24 | ||
| Low | 1.92 on 09/23/24 | 2.05 on 11/21/24 | 1.46 on 10/18/24 | ||
| High | 3.55 on 10/24/24 | 5.00 on 10/02/24 | 7.63 on 08/28/24 | ||
| 6-Month | |||||
| %Chg | -39.04% since 05/22/24 | -52.53% since 05/22/24 | +135.09% since 05/22/24 | ||
| Low | 1.92 on 09/23/24 | 2.05 on 11/21/24 | 0.75 on 05/24/24 | ||
| High | 4.69 on 05/23/24 | 5.59 on 07/26/24 | 9.00 on 08/19/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 6,837 | 7,047 | 6,499 | ||
| Shares Outstanding, K | 2,234 | 3,247 | 3,233 | ||
| Annual Sales | 0 | 0 | 160,000 | ||
| Annual Net Income | -7,600,000 | -8,370,000 | -6,730,000 | ||
| Last Quarter Sales | 0 | 0 | N/A | ||
| Last Quarter Net Income | -3,410,000 | -1,670,000 | N/A | ||
| 60-Month Beta | 0.57 | 0.84 | 1.94 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -1.53 on 11/14/24 | -0.52 on 08/09/24 | N/A | ||
| Latest Earnings Date | 11/20/24 | 12/20/24 | 11/19/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||